Impact of Comorbid Disease Burden on Clinical Outcomes of Female Acute Myocardial Infarction Patients
- PMID: 36794246
- PMCID: PMC9900217
- DOI: 10.4068/cmj.2023.59.1.61
Impact of Comorbid Disease Burden on Clinical Outcomes of Female Acute Myocardial Infarction Patients
Abstract
Owing to the paucity of information on the clinical outcomes in female patients with acute myocardial infarction (AMI) in relation to the comorbid disease burden, we explored the differences in their clinical outcomes and identified predictive indicators. A total of 3,419 female AMI patients were stratified into two groups: Group A (those with zero or one comorbid diseases) (n=1,983) and Group B (those with two to five comorbid diseases) (n=1,436). Five comorbid conditions were considered: hypertension, diabetes mellitus, dyslipidemia, prior coronary artery disease, and prior cerebrovascular accidents. The primary outcome was major adverse cardiac and cerebrovascular events (MACCEs). The incidence of MACCEs was higher in Group B than in Group A in both the unadjusted and propensity score-matched data. Among the comorbid conditions, hypertension, diabetes mellitus, and prior coronary artery disease were found to be independently associated with an increased incidence of MACCEs. Higher comorbid disease burden was positively associated with adverse outcomes in the female population with AMI. Since both hypertension and diabetes mellitus are modifiable and independent predictors of adverse outcomes after AMI, it may be necessary to focus on the optimal management of blood pressure and glucose levels to improve cardiovascular outcomes.
Keywords: Female; Multimorbidity; Myocardial infarction; Treatment outcome.
© Chonnam Medical Journal, 2023.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT: None declared.
Figures
References
-
- Jagannathan R, Patel SA, Ali MK, Narayan KMV. Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr Diab Rep. 2019;19:44. - PubMed
-
- Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–1423. Erratum in: J Am Coll Cardiol 2012;59:1663. - PMC - PubMed
-
- Gili M, Sala J, López J, Carrión A, Béjar L, Moreno J, et al. [Impact of comorbidities on in-hospital mortality from acute myocardial infarction, 2003-2009] Rev Esp Cardiol. 2011;64:1130–1137. Spanish. - PubMed
-
- Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21–S29. - PubMed
LinkOut - more resources
Full Text Sources
